۱۳۹۸ يکشنبه ۴ اسفند

 

Authors

Title

Source title

Volume

Issue

Page start

Page end

1

Hakimi Parizi M., Pardakhty A., Sharifi I., Farajzadeh S., Daie Parizi M.H., Sharifi H., Keyhani A.R., Mostafavi M., Bamorovat M., Ghaffari D.

Antileishmanial activity and immune modulatory effects of benzoxonium chloride and its entrapped forms in niosome on Leishmania tropica

Journal of Parasitic Diseases

43

3

406

415

2

Parizi M.H., Farajzadeh S., Sharifi I., Pardakhty A., Parizi M.H.D., Sharifi H., Salarkia E., Hassanzadeh S.

Antileishmanial Activity of Niosomal Combination Forms of Tioxolone along with Benzoxonium Chloride against Leishmania tropica

The Korean journal of parasitology

57

4

359

368

3

Mehravaran A., Rezaei Nasab M., Mirahmadi H., Sharifi I., Alijani E., Reza Nikpoor A., Akhtari J., Hojatizade M.

Immunogenicity and protection effects of cationic liposome containing imiquimod adjuvant on leishmaniasis in BALB/c mice

Iranian Journal of Basic Medical Sciences

22

8

922

931

4

Hakimi Parizi M., Sharifi I., Farajzadeh S., Pardakhty A., Parizi M., Sharifi H., Keyhani A., Mostafavi M., Bamorovat M., Khosravi A., Ghaffari D.

Tioxolone niosomes exert antileishmanial effects on Leishmania tropica by promoting promastigote apoptosis and immunomodulation

Asian Pacific Journal of Tropical Medicine

12

8

365

374

5

Mostafavi M., Sharifi I., Farajzadeh S., Khazaeli P., Sharifi H., Pourseyedi E., Kakooei S., Bamorovat M., Keyhani A., Parizi M.H., Khosravi A., Khamesipour A.

Niosomal formulation of amphotericin B alone and in combination with glucantime: In vitro and in vivo leishmanicidal effects

Biomedicine and Pharmacotherapy

116

     

6

Razavinasab S.Z., Sharifi I., Aflatoonian M.R., Babaei Z., Mohammadi M.A., Salarkia E., Sharifi F., Aghaei Afshar A., Bamorovat M.

Expansion of urban cutaneous leishmaniasis into rural areas of southeastern Iran: Clinical, epidemiological and phylogenetic profiles explored using 7SL high resolution melting-PCR analysis

Transboundary and Emerging Diseases

66

4

1602

1610

7

Mostafavi M., Farajzadeh S., Sharifi I., Khazaeli P., Sharifi H.

Leishmanicidal effects of amphotericin B in combination with selenium loaded on niosome against Leishmania tropica

Journal of Parasitic Diseases

43

2

176

185

8

Tohidi F., Babaei Z., Kazemi B., Bandehpour M., Sharifi I., Rabiei M., Dezaki E.

Transient knockdown of Nucleoside transporter 4 gene expression as a therapeutic target in Leishmania major by antisense RNA: In vitro and in vivo studies

Journal of Vector Borne Diseases

56

2

98

104

9

Mehravaran A., Nasab M.R., Mirahmadi H., Sharifi I., Alijani E., Nikpoor A.R., Akhtari J.

Protection induced by Leishmania Major antigens and the imiquimod adjuvant encapsulated on liposomes in experimental cutaneous leishmaniasis

Infection, Genetics and Evolution

70

 

27

35

10

Aflatoonian M.R., Sharifi I., Aflatoonian B., Bamorovat M., Heshmatkhah A., Babaei Z., Almani P.G.N., Mohammadi M.A., Salarkia E., Afshar A.A., Sharifi H., Sharifi F., Khosravi A., Khatami M., Arefinia N., Fekri A., Farajzadeh S., Khamesipour A., Mohebali M., Gouya M.M., Shirzadi M.R., Varma R.S.

Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran

PLoS Neglected Tropical Diseases

13

6

 

11

Bamorovat M., Sharifi I., Aflatoonian M.R., Sadeghi B., Shafiian A., Oliaee R.T., Keyhani A., Afshar A.A., Khosravi A., Mostafavi M., Parizi M.H., Khatami M., Arefinia N.

Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways

International Immunopharmacology

69

 

321

327

12

Khosravi A., Sharifi I., Tavakkoli H., Keyhani A.R., Afgar A., Salari Z., Bamorovat M., Sharifi F., Khaleghi T., Varma R.S., Dabiri S., Nematollahi-Mahani S.N., Babaee A., Mostafavi M., Hakimi Parizi M., Derakhshanfar A., Salarkia E.

Toxico-pathological effects of meglumine antimoniate on human umbilical vein endothelial cells

Toxicology in Vitro

56

 

10

18

13

Bamorovat M., Sharifi I., Fekri A., Keyhani A., Aflatoonian M.R., Heshmatkhah A., Oliaee R.T., Khosravi A., Naderi A., Parizi M.H., Mostafavi M., Varma R.S.

A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models

Microbial Pathogenesis

128

 

162

170

14

Mostafavi M., Khazaeli P., Sharifi I., Farajzadeh S., Sharifi H., Keyhani A., Parizi M.H., Kakooei S.

A novel niosomal combination of selenium coupled with glucantime against Leishmania tropica

Korean Journal of Parasitology

57

1

1

8

15

Tohidi F., Kazemi B., Bandehpour M., Sharifi I., Rabiei M.R., Saedi Dezaki E., Babaei Z.

Transient down-regulation of nucleoside transporter 3 gene expression as a drug target in leishmania major using antisense RNA technology

Iranian Journal of Parasitology

14

1

111

119

16

Jafarzadeh A., Nemati M., Sharifi I., Nair A., Shukla D., Chauhan P., Khorramdelazad H., Sarkar A., Saha B.

Leishmania species-dependent functional duality of toll-like receptor 2

IUBMB Life

     

17

Oliaee R.T., Sharifi I., Afgar A., Jafarzadeh A., Kareshk A.T., Bamorovat M., Sharifi H., Babaei Z., Keyhani A., Keyhani A., Abedi L., Sharifi F.

Differential expression of TLRs 2, 4, 9, iNOS and TNF-α and arginase activity in peripheral blood monocytes from glucantime unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis caused by Leishmania tropica

Microbial Pathogenesis

126

 

368

378